Yoichi Mizutani
- Molecular Biology top 10%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Urology top 1%
- Co-authors
- Tsuneharu MikiAkihiro KawauchiOsamu UkimuraKoji OkiharaTakumi ShiraishiToshiyuki SakaiBenjamin BonavidaYoichi Shimada
- Topics
- Renal cell carcinoma treatment (17 papers)Urinary Bladder and Prostate Research (17 papers)Bladder and Urothelial Cancer Treatments (15 papers)
- Cited by
- UrologyCancer ResearchOncology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Yoichi Mizutani
126 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 1.2k
- Surgery 740
- Pulmonary and Respiratory Medicine 537
- Oncology 513
- Urology 314
Countries citing papers authored by Yoichi Mizutani
This map shows the geographic impact of Yoichi Mizutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Mizutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Mizutani more than expected).
Fields of papers citing papers by Yoichi Mizutani
This network shows the impact of papers produced by Yoichi Mizutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Mizutani. The network helps show where Yoichi Mizutani may publish in the future.
Co-authorship network of co-authors of Yoichi Mizutani
This figure shows the co-authorship network connecting the top 25 collaborators of Yoichi Mizutani. A scholar is included among the top collaborators of Yoichi Mizutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichi Mizutani. Yoichi Mizutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 13 | |
| 3 | 4 | |
| 4 | Indication of Neuro-selective Pathogenesis in Individual Patients with Overactive Bladder or Painful Bladder Syndrome by Measure of Current Perception Threshold of the Bladder Afferent Fibers | 1 |
| 5 | 19 | |
| 6 | 6 | |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 7 | |
| 10 | Overexpression of inhibitor of apoptosis protein XIAP in human prostate cancer | 1 |
| 11 | 21 | |
| 12 | 36 | |
| 13 | 39 | |
| 14 | 17 | |
| 15 | 23 | |
| 16 | 35 | |
| 17 | 9 | |
| 18 | 12 | |
| 19 | 3 | |
| 20 | 17 |
About Yoichi Mizutani
Yoichi Mizutani is a scholar working on Urology, Pulmonary and Respiratory Medicine and Oncology, having authored 130 papers that have together received 3.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (17 papers), Urinary Bladder and Prostate Research (17 papers) and Bladder and Urothelial Cancer Treatments (15 papers). The work is most often cited by research in Urology (314 citations), Cancer Research (309 citations) and Oncology (513 citations). Yoichi Mizutani has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tsuneharu Miki, Akihiro Kawauchi, Osamu Ukimura, Koji Okihara, Takumi Shiraishi, Toshiyuki Sakai, Benjamin Bonavida, Yoichi Shimada, Osamu Yoshida and Hiroyuki Nakanishi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.